Clinical Trials Browser

Biological Assay × Clear all

NCT05642195 2026-03-18

Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer

Phase 1/2 Suspended

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasm, Residual

NCT06253494 2026-03-03

Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer

Phase 1/2 Recruiting

Endometrial Neoplasms

NCT06716580 2025-12-10

EQUAL

Phase NA Recruiting

Lung Neoplasms

NCT06954805 2025-05-02

Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

Phase 2 Recruiting

Lymphoma, Lymphoproliferative Disorders, Lymphoma, B-Cell

NCT00551278 2016-01-12

Validation Study Using the GeneSearch BLN Assay to Test Sentinel Lymph Nodes From Patients With Breast Cancer

Breast Neoplasms, Neoplasm Metastasis

NCT00595023 2016-01-12

GeneSearch Breast Lymph Node (BLN) Assay Timing Study

Breast Neoplasms, Neoplasm Metastasis

NCT00595296 2016-01-12

GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study

Breast Neoplasms, Neoplasm Metastasis

NCT00869674 2013-05-30

GeneSearch™ Breast Lymph Node (BLN) Assay China Registration Study

Phase 3 Terminated

Breast Neoplasms